Drug Trial Radar · NCT06497127
A Study in Patients With Mixed Dyslipidemia
Last checked: Nov 20, 2026Latest source record: Jan 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
145
Actual
Start
Feb 28, 2024
Primary completion
Jun 30, 2026
Study completion Mar 30, 2028
Sponsor
- Lead sponsor
- Shanghai Argo Biopharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jul 11, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Phase 2 in Patients With Mixed Dyslipidemia
Conditions
- Mixed Dyslipidemia
Interventions
BW-00112Drug
BW-00112 or volume-matched placebo on Day 1 and Day 90
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent change in fasting TGTime frame: From baseline to Day 180
Locations
14 sites in 1 country. Site status is shown where the registry gives one.
Alliance for Multispecialty Research, LLC
Daphne, Alabama
Alliance for Multispecialty Research, LLC
Mobile, Alabama
Excel Medical Clinical Trials, LLC, dba Flourish Research
Boca Raton, Florida
East Coast Institute for Research, LLC
Jacksonville, Florida
Clinical Site Partners Leesburg, LLC dba Flourish Research
Leesburg, Florida
Suncoast Research Group, LLC DBA Flourish Research
Miami, Florida
Clinical Site Partners, LLC DBA Flourish Research
Miami, Florida
East Coast Institute for Research LLC
Canton, Georgia
Alliance for Multispecialty Research, LLC
Oak Brook, Illinois
Alliance for Multispecialty Research, LLC
Park Ridge, Illinois
Alliance for Multispecialty Research, LLC
Newton, Kansas
Icahn School of Medicine at Mount Sinai
New York, New York
Alliance for Multispecialty Research, LLC
Norman, Oklahoma
Clinical Trials of Texas, LLC
San Antonio, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.